Cigna Group confirmed it is "not pursuing a combination with Humana, a big provider of Medicare Advantage coveage.

(Reuters) - Cigna Group is not pursuing a combination with Humana ... Medicare-focused insurers such as Humana have been ...

In a report released yesterday, Erin Wright from Morgan Stanley maintained a Buy rating on Cigna (CI – Research Report), with a price ...

“In light of recent and persistent speculation, The Cigna Group expects to communicate that the company is not pursuing a combination with Humana Inc. The Cigna Group remains committed to its ...

1 Day CI 7.28% DJIA 0.69% S&P 500 0.10% Financial Services 0.53% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the ...

Analyst Steve Baxter of Wells Fargo maintained a Hold rating on Cigna (CI – Research Report), retaining the price target of $355.00.

Cigna Group is not pursuing a combination with rival Humana, the health insurer said on Monday, days after Donald Trump's ...

The company sees strong interest in tailored provider networks that cater to employee needs, as well as obesity drug cost ...

The Cigna Group (NYSE: CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to ...

Shares of Cigna Group CI inched 0.09% higher to $319.77 Friday, on what proved to be an all-around great trading session for ...

Shares of Cigna Group CI rose 1.35% to $319.49 Thursday, on what proved to be an all-around mixed trading session for the ...

The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to ...